Graig Suvannavejh
Stock Analyst at Mizuho Securities
(4.83)
# 469
Out of 5,126 analysts
890
Total ratings
44.9%
Success rate
18%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Graig Suvannavejh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMLX Amylyx Pharmaceuticals | Reiterated: Buy | $38 → $39 | $31.80 | +22.64% | 48 | Nov 10, 2026 | |
| IDYA IDEAYA Biosciences | Reiterated: Buy | $44 → $39 | $32.72 | +19.21% | 31 | Nov 10, 2026 | |
| RGNX REGENXBIO | Reiterated: Buy | $19 → $18 | $8.47 | +112.51% | 3 | Nov 6, 2026 | |
| TARS Tarsus Pharmaceuticals | Reiterated: Buy | $94 → $102 | $76.76 | +32.88% | 17 | Nov 6, 2026 | |
| AXSM Axsome Therapeutics | Reiterated: Buy | $284 → $272 | $149.24 | +82.26% | 161 | Nov 4, 2026 | |
| INSM Insmed | Reiterated: Buy | $154 → $158 | $120.75 | +30.85% | 61 | Nov 3, 2026 | |
| BLTE Belite Bio | Reiterated: Buy | $234 → $221 | $155.94 | +41.72% | 14 | Oct 29, 2026 | |
| CRBP Corbus Pharmaceuticals Holdings | Reiterated: Buy | $33 → $24 | $4.00 | +500.00% | 28 | Oct 29, 2026 | |
| CRVS Corvus Pharmaceuticals | Reiterated: Buy | $30 → $27 | $11.47 | +135.40% | 24 | Oct 29, 2026 | |
| HRMY Harmony Biosciences Holdings | Reiterated: Buy | $51 → $49 | $34.22 | +43.19% | 85 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $35 → $33 | $31.65 | +4.27% | 33 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $23 | $8.66 | +165.59% | 11 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $11 | $3.79 | +190.24% | 42 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $21 | $6.69 | +213.90% | 26 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $13 | $3.88 | +235.05% | 47 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3 | $0.473 | +534.25% | 27 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $240 → $232 | $163.94 | +41.52% | 11 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $13 | $9.09 | +43.01% | 38 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $7 | $1.89 | +270.37% | 3 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $39 → $0.5 | $0.3566 | +40.21% | 47 | Oct 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 | $2.63 | -42.97% | 40 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $65 | $47.89 | +35.73% | 4 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $5 | $16.80 | -70.24% | 7 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $1,500 → $75 | $0.171 | n/a | 3 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.03 | n/a | 12 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 26.50 → CHF 17.00 | CHF 4.01 | n/a | 2 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €16.50 | €21.00 | n/a | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 → $50 | $101.68 | n/a | 4 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $6.5 | $1.24 | n/a | 2 | Nov 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €14.00 → €6.00 | €2.13 | n/a | 2 | Oct 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | €57.00 → €44.00 | €29.80 | n/a | 3 | Oct 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €14.00 → €14.50 | €2.68 | n/a | 2 | Sep 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $18 → $16 | $112.16 | n/a | 3 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $26 | $58.53 | n/a | 2 | Jul 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €4.00 → €3.50 | €1.39 | n/a | 2 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $135 → $96 | $109.34 | n/a | 5 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $28 | $10.77 | n/a | 1 | Apr 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $31 | $47.57 | n/a | 1 | Apr 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $87.08 | n/a | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 → $55 | $28.38 | n/a | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $7 | $11.88 | n/a | 2 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $97 → $90 | $33.34 | n/a | 2 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $4.75 | $1.59 | n/a | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $128 → $145 | $248.24 | n/a | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $37 | $3.78 | n/a | 1 | Oct 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $19 | $3.69 | n/a | 3 | May 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $60 | $308.81 | n/a | 1 | Sep 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $154 | $977.58 | n/a | 1 | Dec 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $65.76 | n/a | 2 | Sep 23, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10 → $11 | $4.19 | n/a | 5 | Jul 1, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2 → $1 | $0.0003 | n/a | 4 | May 28, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 | $2.31 | n/a | 1 | Apr 1, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 → $96 | $316.83 | n/a | 2 | Feb 13, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $4.13 | n/a | 2 | Feb 3, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $2 | $2.01 | n/a | 3 | Oct 15, 2013 |
Amylyx Pharmaceuticals
Nov 10, 2026
Reiterated: Buy
Price Target: $38 → $39
Current: $31.80
Upside: +22.64%
IDEAYA Biosciences
Nov 10, 2026
Reiterated: Buy
Price Target: $44 → $39
Current: $32.72
Upside: +19.21%
REGENXBIO
Nov 6, 2026
Reiterated: Buy
Price Target: $19 → $18
Current: $8.47
Upside: +112.51%
Tarsus Pharmaceuticals
Nov 6, 2026
Reiterated: Buy
Price Target: $94 → $102
Current: $76.76
Upside: +32.88%
Axsome Therapeutics
Nov 4, 2026
Reiterated: Buy
Price Target: $284 → $272
Current: $149.24
Upside: +82.26%
Insmed
Nov 3, 2026
Reiterated: Buy
Price Target: $154 → $158
Current: $120.75
Upside: +30.85%
Belite Bio
Oct 29, 2026
Reiterated: Buy
Price Target: $234 → $221
Current: $155.94
Upside: +41.72%
Corbus Pharmaceuticals Holdings
Oct 29, 2026
Reiterated: Buy
Price Target: $33 → $24
Current: $4.00
Upside: +500.00%
Corvus Pharmaceuticals
Oct 29, 2026
Reiterated: Buy
Price Target: $30 → $27
Current: $11.47
Upside: +135.40%
Harmony Biosciences Holdings
Oct 29, 2026
Reiterated: Buy
Price Target: $51 → $49
Current: $34.22
Upside: +43.19%
Oct 29, 2026
Reiterated: Hold
Price Target: $35 → $33
Current: $31.65
Upside: +4.27%
Oct 29, 2026
Reiterated: Buy
Price Target: $26 → $23
Current: $8.66
Upside: +165.59%
Oct 29, 2026
Reiterated: Buy
Price Target: $12 → $11
Current: $3.79
Upside: +190.24%
Oct 29, 2026
Reiterated: Buy
Price Target: $25 → $21
Current: $6.69
Upside: +213.90%
Oct 29, 2026
Reiterated: Buy
Price Target: $15 → $13
Current: $3.88
Upside: +235.05%
Oct 29, 2026
Reiterated: Buy
Price Target: $4 → $3
Current: $0.473
Upside: +534.25%
Oct 29, 2026
Reiterated: Buy
Price Target: $240 → $232
Current: $163.94
Upside: +41.52%
Oct 29, 2026
Reiterated: Buy
Price Target: $14 → $13
Current: $9.09
Upside: +43.01%
Oct 29, 2026
Reiterated: Buy
Price Target: $8 → $7
Current: $1.89
Upside: +270.37%
Oct 20, 2026
Downgraded: Hold
Price Target: $39 → $0.5
Current: $0.3566
Upside: +40.21%
Oct 6, 2026
Reiterated: Hold
Price Target: $1.5
Current: $2.63
Upside: -42.97%
Sep 22, 2026
Reiterated: Buy
Price Target: $24 → $65
Current: $47.89
Upside: +35.73%
Dec 9, 2025
Reiterated: Buy
Price Target: $4 → $5
Current: $16.80
Upside: -70.24%
Oct 2, 2025
Downgraded: Hold
Price Target: $1,500 → $75
Current: $0.171
Upside: n/a
Aug 26, 2025
Rated: Hold
Price Target: n/a
Current: $0.03
Upside: n/a
May 5, 2022
Reiterated: Hold
Price Target: CHF 26.50 → CHF 17.00
Current: CHF 4.01
Upside: n/a
May 5, 2022
Reiterated: Hold
Price Target: €16.50
Current: €21.00
Upside: n/a
Nov 15, 2021
Reiterated: Buy
Price Target: $55 → $50
Current: $101.68
Upside: n/a
Nov 9, 2021
Reiterated: Hold
Price Target: $13 → $6.5
Current: $1.24
Upside: n/a
Oct 28, 2021
Reiterated: Buy
Price Target: €14.00 → €6.00
Current: €2.13
Upside: n/a
Oct 5, 2021
Reiterated: Sell
Price Target: €57.00 → €44.00
Current: €29.80
Upside: n/a
Sep 21, 2021
Reiterated: Buy
Price Target: €14.00 → €14.50
Current: €2.68
Upside: n/a
Aug 4, 2021
Reiterated: Sell
Price Target: $18 → $16
Current: $112.16
Upside: n/a
Jul 20, 2021
Reiterated: Hold
Price Target: $16 → $26
Current: $58.53
Upside: n/a
Jun 29, 2021
Reiterated: Hold
Price Target: €4.00 → €3.50
Current: €1.39
Upside: n/a
May 14, 2021
Reiterated: Hold
Price Target: $135 → $96
Current: $109.34
Upside: n/a
Apr 20, 2021
Initiated Coverage: Hold
Price Target: $28
Current: $10.77
Upside: n/a
Apr 19, 2021
Initiated Coverage: Hold
Price Target: $31
Current: $47.57
Upside: n/a
Mar 2, 2021
Initiated Coverage: Buy
Price Target: $20
Current: $87.08
Upside: n/a
Feb 3, 2021
Reiterated: Buy
Price Target: $36 → $55
Current: $28.38
Upside: n/a
Jan 15, 2021
Reiterated: Buy
Price Target: $28 → $7
Current: $11.88
Upside: n/a
Dec 21, 2020
Reiterated: Sell
Price Target: $97 → $90
Current: $33.34
Upside: n/a
Nov 23, 2020
Initiated Coverage: Hold
Price Target: $4.75
Current: $1.59
Upside: n/a
Nov 11, 2020
Reiterated: Sell
Price Target: $128 → $145
Current: $248.24
Upside: n/a
Oct 20, 2020
Initiated Coverage: Hold
Price Target: $37
Current: $3.78
Upside: n/a
May 11, 2020
Reiterated: Buy
Price Target: $14 → $19
Current: $3.69
Upside: n/a
Sep 24, 2019
Initiated Coverage: Hold
Price Target: $60
Current: $308.81
Upside: n/a
Dec 17, 2018
Initiated Coverage: Buy
Price Target: $154
Current: $977.58
Upside: n/a
Sep 23, 2014
Initiated Coverage: Buy
Price Target: $16
Current: $65.76
Upside: n/a
Jul 1, 2014
Downgraded: Hold
Price Target: $10 → $11
Current: $4.19
Upside: n/a
May 28, 2014
Downgraded: Hold
Price Target: $2 → $1
Current: $0.0003
Upside: n/a
Apr 1, 2014
Downgraded: Hold
Price Target: $3
Current: $2.31
Upside: n/a
Feb 13, 2014
Reiterated: Buy
Price Target: $62 → $96
Current: $316.83
Upside: n/a
Feb 3, 2014
Reiterated: Buy
Price Target: $27
Current: $4.13
Upside: n/a
Oct 15, 2013
Downgraded: Hold
Price Target: $15 → $2
Current: $2.01
Upside: n/a